Posting of Circular and Notice of General Meeting

RNS Number : 6929K

Yourgene Health PLC

23 December 2022

 

Yourgene Health plc 

("Yourgene" or the "Company")

 Posting of Circular and Notice of General Meeting

The Board of Yourgene Health plc (AIM: YGEN), is pleased to confirm that, further to the announcements made on 21 December 2022 and 22 December 2022, regarding the proposed Capital Raising, a circular (the "Circular"), including the Notice of General Meeting and a Form of Proxy was posted yesterday to shareholders.

The General Meeting will be held at Skelton House, Lloyd Street North, Manchester Science Park, Manchester M15 6SH  on 9 January 2023 at 4.00 p.m.

A copy of the Circular will shortly be available to download from the Company's website at http://www.yourgene-health.com/investors/key-documents/shareholder-communications .

Unless otherwise defined, all capitalised terms used but not defined in this announcement shall have the meaning given to them in the Circular.

The expected timetable relating to the Capital Raising is set out below.

	2022
Announcement of the Capital Raising	21 December
Announcement of Retail Offer	22 December
Publication and posting of the Circular and Form of Proxy	22 December
First Admission and commencement of dealings in the First Admission Shares	8.00 a.m. on 23 December
CREST stock accounts expected to be credited for the First Admission Shares (where applicable)	23 December
Launch of Retail Offer	23 December
	2023
Posting of share certificates for the First Admission Shares by the Registrar (where applicable)	by no later than 5 January
Latest time and date for receipt of Forms of Proxy and CREST voting instructions	5.00 p.m. on 5 January
Close of Retail Offer	6 January
General Meeting	4.00 p.m. on 9 January
Results of the General Meeting announced through a Regulatory Information Service	9 January
Second Admission and commencement of dealings in the Second Admission Shares and the Retail Shares	8.00 a.m. on 11 January
Where applicable, expected date for CREST accounts to be credited in respect of Second Admission Shares in uncertificated form	11 January
Posting of share certificates for the Second Admission Shares by the Registrar (where applicable)	by no later than 24 January
Long Stop Date	30 January

Each of the times and dates above refer to London time and are subject to change. Any such change will be notified to Shareholders by an announcement through a Regulatory Information Service. All events listed in the above timetable following the General Meeting are conditional on the passing of the Resolutions at the General Meeting.

Enquiries:

Yourgene Health plc Lyn Rees , Chief Executive Officer	Tel: [phone] [e-mail]
Barry Hextall , Chief Financial Officer
Joanne Cross , Director of Marketing
Cairn Financial Advisers LLP (NOMAD)	Tel: [phone]
Liam Murray / James Caithie / Ludovico Lazzaretti
Singer Capital Markets (Corporate Broker)	Tel: [phone]
Aubrey Powell / Tom Salvesen / George Tzimas
Walbrook PR Ltd (Media and Investor Relations)	Tel: [phone] or [e-mail]
Paul McManus / Lianne Applegarth / Alice Woodings	Mob: [phone] / 07407 804 654

 

END

 

 

MSCPPGQCPUPPPUP